Legal Representation
Attorney
Ralph A. Loren
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 31, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 7, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 13, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 13, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 21, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 1, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Sep 30, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Sep 28, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 21, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 21, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 21, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 21, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 21, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 21, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 21, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 15, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, hypogonadism, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory disease, respiratory and infectious diseases, immunological, bacterial, viral and fungal disorders, mental illness, depression, psychosis, bone and mineral diseases, infertility, menopausal symptoms, hormone deficiencies, hypertension, urinary and bladder complications and sleep disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, contraceptives preparations, muscle relaxants, muscle relaxant antagonists; pharmaceutical preparations for use in hormone therapy, pain management, contraception and smoking cessation
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005